Tuberculosis (TB)
Clinical trials for Tuberculosis (TB) explained in plain language.
Never miss a new study
Get alerted when new Tuberculosis (TB) trials appear
Sign up with your email to follow new studies for Tuberculosis (TB), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could this new vaccine end tuberculosis?
Vaccine OngoingThis study tests a new vaccine called MTBVAC to see if it can prevent tuberculosis (TB) disease in teens and adults aged 14 to 45 who live in areas where TB is common. About 5,500 volunteers will receive either the vaccine or a placebo, and researchers will track who develops TB …
Matched conditions: TUBERCULOSIS (TB)
Phase 2 • Sponsor: International AIDS Vaccine Initiative • Aim: Vaccine
Last updated Sep 11, 2026 00:00 UTC
-
New TB vaccine candidate MTBVAC enters Mid-Stage human trial
Vaccine OngoingThis phase II trial tests a new tuberculosis vaccine called MTBVAC (BBV169) in 164 healthy adolescents and adults. Some participants get the new vaccine, others get the standard BCG vaccine. The study checks how safe the vaccine is and how well it triggers an immune response, aim…
Matched conditions: TUBERCULOSIS (TB)
Phase 2 • Sponsor: Bharat Biotech International Limited • Aim: Vaccine
Last updated Jun 27, 2026 12:25 UTC
-
Smartphone Check-Ins could boost TB treatment success
Disease control OngoingThis study tests a digital package called CARE-TB to help people with tuberculosis take their medication as prescribed. The package includes video observation of pill-taking, digital reminders, telecounselling, and educational materials. Researchers will compare this approach to …
Matched conditions: TUBERCULOSIS (TB)
Sponsor: University of Malaya • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC